8AIG

NMR structure of holo-acp

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.0 mM [U-100% 13C; U-100% 15N] virginiamycin ACP6, 100 mM sodium phosphate, 0.5 mM TCEP	90% H2O/10% D2O	0.1 M	6.5	1 atm	298	Bruker AVANCE III 600
11	2D 1H-13C HSQC	1.0 mM [U-100% 13C; U-100% 15N] virginiamycin ACP6, 100 mM sodium phosphate, 0.5 mM TCEP	90% H2O/10% D2O	0.1 M	6.5	1 atm	298	Bruker AVANCE III 600
16	2D 1H-1H(C12,N14) NOESY	1.0 mM [U-100% 13C; U-100% 15N] virginiamycin ACP6, 100 mM sodium phosphate, 0.5 mM TCEP	90% H2O/10% D2O	0.1 M	6.5	1 atm	298	Bruker AVANCE III 600
17	2D 1H(C12,N14)-1H(C12,N14) NOESY	1.0 mM [U-100% 13C; U-100% 15N] virginiamycin ACP6, 100 mM sodium phosphate, 0.5 mM TCEP	90% H2O/10% D2O	0.1 M	6.5	1 atm	298	Bruker AVANCE III 600
10	3D HNCACB	1.0 mM [U-100% 13C; U-100% 15N] virginiamycin ACP6, 100 mM sodium phosphate, 0.5 mM TCEP	90% H2O/10% D2O	0.1 M	6.5	1 atm	298	Bruker AVANCE III 600
9	3D HNCO	1.0 mM [U-100% 13C; U-100% 15N] virginiamycin ACP6, 100 mM sodium phosphate, 0.5 mM TCEP	90% H2O/10% D2O	0.1 M	6.5	1 atm	298	Bruker AVANCE III 600
8	3D HCCH-TOCSY	1.0 mM [U-100% 13C; U-100% 15N] virginiamycin ACP6, 100 mM sodium phosphate, 0.5 mM TCEP	90% H2O/10% D2O	0.1 M	6.5	1 atm	298	Bruker AVANCE III 600
7	3D CCH-TOCSY	1.0 mM [U-100% 13C; U-100% 15N] virginiamycin ACP6, 100 mM sodium phosphate, 0.5 mM TCEP	90% H2O/10% D2O	0.1 M	6.5	1 atm	298	Bruker AVANCE III 600
6	3D 1H-13C NOESY	1.0 mM [U-100% 13C; U-100% 15N] virginiamycin ACP6, 100 mM sodium phosphate, 0.5 mM TCEP	90% H2O/10% D2O	0.1 M	6.5	1 atm	298	Bruker AVANCE III 600
5	3D 1H-15N NOESY	1.0 mM [U-100% 13C; U-100% 15N] virginiamycin ACP6, 100 mM sodium phosphate, 0.5 mM TCEP	90% H2O/10% D2O	0.1 M	6.5	1 atm	298	Bruker AVANCE III 600
15	3D 1H-13C NOESY aromatic	1.0 mM [U-100% 13C; U-100% 15N] virginiamycin ACP6, 100 mM sodium phosphate, 0.5 mM TCEP	90% H2O/10% D2O	0.1 M	6.5	1 atm	298	Bruker AVANCE III 600
4	3D HNCA	1.0 mM [U-100% 13C; U-100% 15N] virginiamycin ACP6, 100 mM sodium phosphate, 0.5 mM TCEP	90% H2O/10% D2O	0.1 M	6.5	1 atm	298	Bruker AVANCE III 600
3	3D HNHA	1.0 mM [U-100% 13C; U-100% 15N] virginiamycin ACP6, 100 mM sodium phosphate, 0.5 mM TCEP	90% H2O/10% D2O	0.1 M	6.5	1 atm	298	Bruker AVANCE III 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600

NMR Refinement
Method	Details	Software
molecular dynamics		Amber

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	50
Conformers Submitted Total Number	20
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	Amber		Case, Darden, Cheatham III, Simmerling, Wang, Duke, Luo, ... and Kollman
2	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
3	chemical shift assignment	NMRFAM-SPARKY		Lee W, Tonelli M, Markley JL
4	peak picking	NMRFAM-SPARKY		Lee W, Tonelli M, Markley JL